The Serum Resistome of a Globally Disseminated Multidrug Resistant Uropathogenic Escherichia coli Clone

PLoS Genetics

Volumn 9, Issue 10, 2013, Pages

  Phan, Minh Duy ^a   Peters, Kate M ^a   Sarkar, Sohinee ^a   Lukowski, Samuel W ^a,c   Allsopp, Luke P ^a   Moriel, Danilo Gomes ^a   Achard, Maud E S ^a   Totsika, Makrina ^a   Marshall, Vikki M ^a   Upton, Mathew ^b   Beatson, Scott A ^a   Schembri, Mark A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF PLYMOUTH   (United Kingdom)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID A; LIPOPOLYSACCHARIDE; LIPOPROTEIN; MEMBRANE PROTEIN;

ACNB GENE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOSYNTHESIS; ENZYME SYNTHESIS; ESCHERICHIA COLI; FBP GENE; GENE EXPRESSION; GENE IDENTIFICATION; GREA GENE; HYXA GENE; HYXR GENE; MULTIDRUG RESISTANCE; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; SERUM RESISTOME; TRANSPOSON;

BETA-LACTAMASES; BLOOD; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MOLECULAR EPIDEMIOLOGY; MUTAGENESIS; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE;

EID: 84887314032     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003834     Document Type: Article

References (122)

1. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, et al. (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61: 273-281.
2. Pitout JD, Gregson DB, Campbell L, Laupland KB, (2009) Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother 53: 2846-2851.
3. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M, (2010) Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 51: 286-294.
4. Peirano G, Pitout JD, (2010) Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 35: 316-321.
5. Sidjabat HE, Derrington P, Nimmo GR, Paterson DL, (2010) Escherichia coli ST131 producing CTX-M-15 in Australia. J Antimicrob Chemother 65: 1301-1303.
6. Rogers BA, Sidjabat HE, Paterson DL, (2011) Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66: 1-14.
7. Ender PT, Gajanana D, Johnston B, Clabots C, Tamarkin FJ, et al. (2009) Transmission of an extended-spectrum-beta-lactamase-producing Escherichia coli (sequence type ST131) strain between a father and daughter resulting in septic shock and Emphysematous pyelonephritis. J Clin Microbiol 47: 3780-3782.
8. Johnson JR, Anderson JT, Clabots C, Johnston B, Cooperstock M, (2010) Within-household sharing of a fluoroquinolone-resistant Escherichia coli sequence type ST131 strain causing pediatric osteoarticular infection. Pediatr Infect Dis J 29: 473-475.
9. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, et al. (2008) Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 14: 195-200.
10. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, et al. (2009) Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 53: 2733-2739.
11. Johnson JR, Tchesnokova V, Johnston B, Clabots C, Roberts PL, et al. (2013) Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli. J Infect Dis 207: 919-928.
12. Peirano G, Schreckenberger PC, Pitout JD, (2011) Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131. Antimicrob Agents Chemother 55: 2986-2988.
13. Morris D, Boyle F, Ludden C, Condon I, Hale J, et al. (2011) Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone. Antimicrob Agents Chemother 55: 4935-4936.
14. Morris D, McGarry E, Cotter M, Passet V, Lynch M, et al. (2012) Detection of OXA-48 carbapenemase in the pandemic clone Escherichia coli O25b:H4-ST131 in the course of investigation of an outbreak of OXA-48-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 56: 4030-4031.
15. Totsika M, Moriel DG, Idris A, Rogers BA, Wurpel DJ, et al. (2012) Uropathogenic Escherichia coli mediated urinary tract infection. Curr Drug Targets 13: 1386-1399.
16. Ulett GC, Totsika M, Schaale K, Carey AJ, Sweet MJ, et al. (2013) Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Curr Opin Microbiol 16: 100-107.
17. Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, et al. (2008) The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 61: 1024-1028.
18. Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E, (2012) Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun 80: 1554-1562.
19. Lavigne JP, Vergunst AC, Goret L, Sotto A, Combescure C, et al. (2012) Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS One 7: e34294.
20. Gibreel TM, Dodgson AR, Cheesbrough J, Bolton FJ, Fox AJ, et al. (2012) High metabolic potential may contribute to the success of ST131 uropathogenic Escherichia coli. J Clin Microbiol 50: 3202-3207.
21. Vimont S, Boyd A, Bleibtreu A, Bens M, Goujon JM, et al. (2012) The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities. PLoS One 7: e46547.
22. Totsika M, Beatson SA, Sarkar S, Phan MD, Petty NK, et al. (2011) Insights into a Multidrug Resistant Escherichia coli Pathogen of the Globally Disseminated ST131 Lineage: Genome Analysis and Virulence Mechanisms. PLoS One 6: e26578.
23. Lau SH, Kaufmann ME, Livermore DM, Woodford N, Willshaw GA, et al. (2008) UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother 62: 1241-1244.
24. Totsika M, Kostakioti M, Hannan TJ, Upton M, Beatson SA, et al. (2013) A FimH Inhibitor Prevents Acute Bladder Infection and Treats Chronic Cystitis Caused by Multidrug-Resistant Uropathogenic Escherichia coli ST131. J Infect Dis 208 (6):: 921-8.
25. Floyd RV, Upton M, Hultgren SJ, Wray S, Burdyga TV, et al. (2012) Escherichia coli-mediated impairment of ureteric contractility is uropathogenic E. coli specific. J Infect Dis 206: 1589-1596.
26. McCabe WR, Kaijser B, Olling S, Uwaydah M, Hanson LA, (1978) Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J Infect Dis 138: 33-41.
27. Martínez JL, Cercenado E, Pérez-Díaz JC, Baquero F, (1986) Multifactorial determination of systemic invasivity in Escherichia coli. FEMS Microbiology Letters 37: 259-261.
28. Jacobson SH, ÖStenson C-G, Tullus K, Brauner A, (1992) Serum resistance in Escherichia coli strains causing acute pyelonephritis and bacteraemia. APMIS 100: 147-153.
29. Opal S, Cross A, Gemski P, (1982) K antigen and serum sensitivity of rough Escherichia coli. Infect Immun 37: 956-960.
30. Feingold DS, (1969) The serum bactericidal reaction. IV. Phenotypic conversion of Escherichia coli from serum-resistance to serum-sensitivity by diphenylamine. J Infect Dis 120: 437-444.
31. Gemski P, Cross AS, Sadoff JC, (1980) K1 antigen-associated resistance to the bactericidal activity of serum. FEMS Microbiology Letters 9: 193-197.
32. Stawski G, Nielsen L, ØRskov F, ØRskov IDA, (1990) Serum sensitivity of a diversity of Escherichia coli antigenic reference strains. APMIS 98: 828-838.
33. Cross AS, Kim KS, Wright DC, Sadoff JC, Gemski P, (1986) Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains of Escherichia coli. J Infect Dis 154: 497-503.
34. Burns SM, Hull SI, (1998) Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5. Infect Immun 66: 4244-4253.
35. Porat R, Mosseri R, Kaplan E, Johns MA, Shibolet S, (1992) Distribution of polysaccharide side chains of lipopolysaccharide determine resistance of Escherichia coli to the bactericidal activity of serum. J Infect Dis 165: 953-956.
36. Weiser JN, Gotschlich EC, (1991) Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect Immun 59: 2252-2258.
37. Moll A, Manning PA, Timmis KN, (1980) Plasmid-determined resistance to serum bactericidal activity: a major outer membrane protein, the traT gene product, is responsible for plasmid-specified serum resistance in Escherichia coli. Infect Immun 28: 359-367.
38. Montenegro MA, Bitter-Suermann D, Timmis JK, Aguero ME, Cabello FC, et al. (1985) traT gene sequences, serum resistance and pathogenicity-related factors in clinical isolates of Escherichia coli and other gram-negative bacteria. J Gen Microbiol 131: 1511-1521.
39. Smith HW, (1974) A search for transmissible pathogenic characters in invasive strains of Escherichia coli: the discovery of a plasmid-controlled toxin and a plasmid-controlled lethal character closely associated, or identical, with colicine V. J Gen Microbiol 83: 95-111.
40. Barondess JJ, Beckwith J, (1995) bor gene of phage lambda, involved in serum resistance, encodes a widely conserved outer membrane lipoprotein. J Bacteriol 177: 1247-1253.
41. Christen B, Abeliuk E, Collier JM, Kalogeraki VS, Passarelli B, et al. (2011) The essential genome of a bacterium. Mol Syst Biol 7: 528.
42. Langridge GC, Phan MD, Turner DJ, Perkins TT, Parts L, et al. (2009) Simultaneous assay of every Salmonella Typhi gene using one million transposon mutants. Genome Res 19: 2308-2316.
43. Goodman AL, McNulty NP, Zhao Y, Leip D, Mitra RD, et al. (2009) Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe 6: 279-289.
44. Gawronski JD, Wong SM, Giannoukos G, Ward DV, Akerley BJ, (2009) Tracking insertion mutants within libraries by deep sequencing and a genome-wide screen for Haemophilus genes required in the lung. Proc Natl Acad Sci U S A 106: 16422-16427.
45. van Opijnen T, Bodi KL, Camilli A, (2009) Tn-seq: high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms. Nat Methods 6: 767-772.
46. Barquist L, Langridge GC, Turner DJ, Phan MD, Turner AK, et al. (2013) A comparison of dense transposon insertion libraries in the Salmonella serovars Typhi and Typhimurium. Nucleic Acids Res 41 (8):: 4549-64.
47. Datsenko KA, Wanner BL, (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97: 6640-6645.
48. Robinson MD, McCarthy DJ, Smyth GK, (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26: 139-140.
49. Whang HY, Neter E, (1973) Production of common enterobacterial antigen by members of the family Enterobacteriaceae. Experientia 29: 96-97.
50. Makela PH, Mayer H, (1976) Enterobacterial common antigen. Bacteriol Rev 40: 591-632.
51. Beutin L, Manning PA, Achtman M, Willetts N, (1981) sfrA and sfrB products of Escherichia coli K-12 are transcriptional control factors. J Bacteriol 145: 840-844.
52. Bailey MJ, Hughes C, Koronakis V, (1996) Increased distal gene transcription by the elongation factor RfaH, a specialized homologue of NusG. Mol Microbiol 22: 729-737.
53. Nagy G, Dobrindt U, Schneider G, Khan AS, Hacker J, et al. (2002) Loss of regulatory protein RfaH attenuates virulence of uropathogenic Escherichia coli. Infect Immun 70: 4406-4413.
54. Nagy G, Dobrindt U, Grozdanov L, Hacker J, Emody L, (2005) Transcriptional regulation through RfaH contributes to intestinal colonization by Escherichia coli. FEMS Microbiol Lett 244: 173-180.
55. Wang Q, Wang S, Beutin L, Cao B, Feng L, et al. (2010) Development of a DNA microarray for detection and serotyping of enterotoxigenic Escherichia coli. J Clin Microbiol 48: 2066-2074.
56. Stevenson G, Neal B, Liu D, Hobbs M, Packer NH, et al. (1994) Structure of the O antigen of Escherichia coli K-12 and the sequence of its rfb gene cluster. J Bacteriol 176: 4144-4156.
57. Kenne L, Lindberg B, Madden JK, Lindberg AA, Gemski P Jr, (1983) Structural studies of the Escherichia coli O-antigen 25. Carbohydr Res 122: 249-256.
58. Fundin J, Weintraub A, Xu J-G, Widmalm G, (2003) NMR analysis of the O-antigen polysaccharide from Escherichia coli strain F171. Magnetic Resonance in Chemistry 41: 202-205.
59. Liu D, Cole RA, Reeves PR, (1996) An O-antigen processing function for Wzx (RfbX): a promising candidate for O-unit flippase. J Bacteriol 178: 2102-2107.
60. Han X, Dorsey-Oresto A, Malik M, Wang JY, Drlica K, et al. (2010) Escherichia coli genes that reduce the lethal effects of stress. BMC Microbiol 10: 35.
61. Allen MJ, White GF, Morby AP, (2006) The response of Escherichia coli to exposure to the biocide polyhexamethylene biguanide. Microbiology 152: 989-1000.
62. Franco AV, Liu D, Reeves PR, (1998) The wzz (cld) protein in Escherichia coli: amino acid sequence variation determines O-antigen chain length specificity. J Bacteriol 180: 2670-2675.
63. Stenutz R, Weintraub A, Widmalm G, (2006) The structures of Escherichia coli O-polysaccharide antigens. FEMS Microbiol Rev 30: 382-403.
64. Lundborg M, Modhukur V, Widmalm G, (2010) Glycosyltransferase functions of E. coli O-antigens. Glycobiology 20: 366-368.
65. Schnaitman CA, Klena JD, (1993) Genetics of lipopolysaccharide biosynthesis in enteric bacteria. Microbiol Rev 57: 655-682.
66. Raetz CR, Whitfield C, (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71: 635-700.
67. Marolda CL, Tatar LD, Alaimo C, Aebi M, Valvano MA, (2006) Interplay of the Wzx translocase and the corresponding polymerase and chain length regulator proteins in the translocation and periplasmic assembly of lipopolysaccharide o antigen. J Bacteriol 188: 5124-5135.
68. Alexander DC, Valvano MA, (1994) Role of the rfe gene in the biosynthesis of the Escherichia coli O7-specific lipopolysaccharide and other O-specific polysaccharides containing N-acetylglucosamine. J Bacteriol 176: 7079-7084.
69. Danese PN, Pratt LA, Kolter R, (2000) Exopolysaccharide production is required for development of Escherichia coli K-12 biofilm architecture. J Bacteriol 182: 3593-3596.
70. Bateman SL, Seed PC, (2012) Epigenetic regulation of the nitrosative stress response and intracellular macrophage survival by extraintestinal pathogenic Escherichia coli. Mol Microbiol 83: 908-925.
71. Allsopp LP, Beloin C, Ulett GC, Valle J, Totsika M, et al. (2012) Molecular characterization of UpaB and UpaC, two new autotransporter proteins of uropathogenic Escherichia coli CFT073. Infect Immun 80: 321-332.
72. Keseler IM, Collado-Vides J, Santos-Zavaleta A, Peralta-Gil M, Gama-Castro S, et al. (2011) EcoCyc: a comprehensive database of Escherichia coli biology. Nucleic Acids Res 39: D583-590.
73. Yem DW, Wu HC, (1978) Physiological characterization of an Escherichia coli mutant altered in the structure of murein lipoprotein. J Bacteriol 133: 1419-1426.
74. Vadillo-Rodriguez V, Schooling SR, Dutcher JR, (2009) In situ characterization of differences in the viscoelastic response of individual gram-negative and gram-positive bacterial cells. J Bacteriol 191: 5518-5525.
75. Cascales E, Lloubes R, Sturgis JN, (2001) The TolQ-TolR proteins energize TolA and share homologies with the flagellar motor proteins MotA-MotB. Mol Microbiol 42: 795-807.
76. Walburger A, Lazdunski C, Corda Y, (2002) The Tol/Pal system function requires an interaction between the C-terminal domain of TolA and the N-terminal domain of TolB. Mol Microbiol 44: 695-708.
77. Onufryk C, Crouch ML, Fang FC, Gross CA, (2005) Characterization of six lipoproteins in the sigmaE regulon. J Bacteriol 187: 4552-4561.
78. Nikaido H, Vaara M, (1985) Molecular basis of bacterial outer membrane permeability. Microbiol Rev 49: 1-32.
79. Yan A, Guan Z, Raetz CR, (2007) An undecaprenyl phosphate-aminoarabinose flippase required for polymyxin resistance in Escherichia coli. J Biol Chem 282: 36077-36089.
80. Trent MS, Ribeiro AA, Doerrler WT, Lin S, Cotter RJ, et al. (2001) Accumulation of a polyisoprene-linked amino sugar in polymyxin-resistant Salmonella typhimurium and Escherichia coli: structural characterization and transfer to lipid A in the periplasm. J Biol Chem 276: 43132-43144.
81. Raetz CR, Reynolds CM, Trent MS, Bishop RE, (2007) Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem 76: 295-329.
82. Frick DN, Townsend BD, Bessman MJ, (1995) A novel GDP-mannose mannosyl hydrolase shares homology with the MutT family of enzymes. J Biol Chem 270: 24086-24091.
83. Fraenkel DG, Levisohn SR, (1967) Glucose and gluconate metabolism in an Escherichia coli mutant lacking phosphoglucose isomerase. J Bacteriol 93: 1571-1578.
84. Fraenkel DG, Horecker BL, (1965) Fructose-1, 6-diphosphatase and acid hexose phosphatase of Escherichia coli. J Bacteriol 90: 837-842.
85. Prasadarao NV, Blom AM, Villoutreix BO, Linsangan LC, (2002) A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1. J Immunol 169: 6352-6360.
86. Hellman J, Loiselle PM, Tehan MM, Allaire JE, Boyle LA, et al. (2000) Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum. Infect Immun 68: 2566-2572.
87. Kircher M, Heyn P, Kelso J, (2011) Addressing challenges in the production and analysis of illumina sequencing data. BMC Genomics 12: 382.
88. Krueger F, Andrews SR, Osborne CS, (2011) Large scale loss of data in low-diversity illumina sequencing libraries can be recovered by deferred cluster calling. PLoS One 6: e16607.
89. Crimmins GT, Mohammadi S, Green ER, Bergman MA, Isberg RR, et al. (2012) Identification of MrtAB, an ABC transporter specifically required for Yersinia pseudotuberculosis to colonize the mesenteric lymph nodes. PLoS Pathog 8: e1002828.
90. Gallagher LA, Shendure J, Manoil C, (2011) Genome-scale identification of resistance functions in Pseudomonas aeruginosa using Tn-seq. MBio 2: e00315-00310.
91. van Opijnen T, Camilli A, (2013) Transposon insertion sequencing: a new tool for systems-level analysis of microorganisms. Nat Rev Microbiol 11: 435-442.
92. Barquist L, Boinett CJ, Cain AK, (2013) Approaches to querying bacterial genomes with transposon-insertion sequencing. RNA Biol 10: 1161-9.
93. Koonin EV, (2003) Comparative genomics, minimal gene-sets and the last universal common ancestor. Nat Rev Microbiol 1: 127-136.
94. Fang G, Rocha E, Danchin A, (2005) How essential are nonessential genes? Mol Biol Evol 22: 2147-2156.
95. Gerdes S, Edwards R, Kubal M, Fonstein M, Stevens R, et al. (2006) Essential genes on metabolic maps. Curr Opin Biotechnol 17: 448-456.
96. Gerdes SY, Scholle MD, Campbell JW, Balazsi G, Ravasz E, et al. (2003) Experimental determination and system level analysis of essential genes in Escherichia coli MG1655. J Bacteriol 185: 5673-5684.
97. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, et al. (2006) Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2: 2006 0008.
98. Taylor PW, (1975) Genetical studies of serum resistance in Escherichia coli. J Gen Microbiol 89: 57-66.
99. Russo TA, Sharma G, Brown CR, Campagnari AA, (1995) Loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo. Infect Immun 63: 1263-1269.
100. Buckles EL, Wang X, Lane MC, Lockatell CV, Johnson DE, et al. (2009) Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance. J Infect Dis 199: 1689-1697.
101. Leying H, Suerbaum S, Kroll HP, Stahl D, Opferkuch W, (1990) The capsular polysaccharide is a major determinant of serum resistance in K-1-positive blood culture isolates of Escherichia coli. Infect Immun 58: 222-227.
102. Whitfield C, (2006) Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem 75: 39-68.
103. Stevenson G, Andrianopoulos K, Hobbs M, Reeves PR, (1996) Organization of the Escherichia coli K-12 gene cluster responsible for production of the extracellular polysaccharide colanic acid. J Bacteriol 178: 4885-4893.
104. White RJ, (1968) Control of amino sugar metabolism in Escherichia coli and isolation of mutants unable to degrade amino sugars. Biochem J 106: 847-858.
105. Park JT, Uehara T, (2008) How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan). Microbiol Mol Biol Rev 72: 211-227.
106. Adhya S, Schwartz M, (1971) Phosphoglucomutase mutants of Escherichia coli K-12. J Bacteriol 108: 621-626.
107. Inoue T, Shingaki R, Hirose S, Waki K, Mori H, et al. (2007) Genome-wide screening of genes required for swarming motility in Escherichia coli K-12. J Bacteriol 189: 950-957.
108. Lu M, Kleckner N, (1994) Molecular cloning and characterization of the pgm gene encoding phosphoglucomutase of Escherichia coli. J Bacteriol 176: 5847-5851.
109. Frey PA, (1996) The Leloir pathway: a mechanistic imperative for three enzymes to change the stereochemical configuration of a single carbon in galactose. FASEB J 10: 461-470.
110. Weissborn AC, Liu Q, Rumley MK, Kennedy EP, (1994) UTP: alpha-D-glucose-1-phosphate uridylyltransferase of Escherichia coli: isolation and DNA sequence of the galU gene and purification of the enzyme. J Bacteriol 176: 2611-2618.
111. Li H, Ruan J, Durbin R, (2008) Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res 18: 1851-1858.
112. Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, et al. (2000) Artemis: sequence visualization and annotation. Bioinformatics 16: 944-945.
113. Stothard P, Wishart DS, (2005) Circular genome visualization and exploration using CGView. Bioinformatics 21: 537-539.
114. Sullivan MJ, Petty NK, Beatson SA, (2011) Easyfig: a genome comparison visualizer. Bioinformatics 27: 1009-1010.
115. Robinson MD, Oshlack A, (2010) A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol 11: R25.
116. Robinson MD, Smyth GK, (2008) Small-sample estimation of negative binomial dispersion, with applications to SAGE data. Biostatistics 9: 321-332.
117. Robinson MD, Smyth GK, (2007) Moderated statistical tests for assessing differences in tag abundance. Bioinformatics 23: 2881-2887.
118. Allsopp LP, Totsika M, Tree JJ, Ulett GC, Mabbett AN, et al. (2010) UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073. Infect Immun 78: 1659-1669.
119. Martinez E, Bartolome B, de la Cruz F, (1988) pACYC184-derived cloning vectors containing the multiple cloning site and lacZ alpha reporter gene of pUC8/9 and pUC18/19 plasmids. Gene 68: 159-162.
120. Wiegand I, Hilpert K, Hancock RE, (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3: 163-175.
121. West NP, Jungnitz H, Fitter JT, McArthur JD, Guzman CA, et al. (2000) Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence. Infect Immun 68: 4673-4680.
122. Tsai CM, Frasch CE, (1982) A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 119: 115-119.